Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

AbbVie Inc. recalls Synthroid

Class IIIofficial

FDA Class III

FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).

Hazard
Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.
Products
  • Synthroid
Where it was sold

Distributed in the US. No government or foreign consignees.

Units affected
864 cartons
About this recall
Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11